Učitavanje...
Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial
CONTEXT: Pioglitazone reduces cardiovascular risk in nondiabetic patients after an ischemic stroke or transient ischemic attack (TIA) but is associated with increased risk for bone fracture. OBJECTIVE: To characterize fractures associated with pioglitazone by location, mechanism, severity, timing, a...
Spremljeno u:
| Izdano u: | J Clin Endocrinol Metab |
|---|---|
| Glavni autori: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Endocrine Society
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5460686/ https://ncbi.nlm.nih.gov/pubmed/27935736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2016-3237 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|